Literature DB >> 26274343

PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Jaroslaw Jendrzejewski1, Andrew Thomas1, Sandya Liyanarachchi1, Andrew Eiterman1, Jerneja Tomsic1, Huiling He1, Hanna S Radomska1, Wei Li1, Rebecca Nagy1, Krzysztof Sworczak1, Albert de la Chapelle1.   

Abstract

CONTEXT: We previously showed that a long noncoding RNA gene, PTCSC3, located close to the variant rs944289 that predisposes to papillary thyroid carcinoma (PTC) might target the S100A4 gene.
OBJECTIVE: The aim was to investigate the impact of PTCSC3 on S100A4 expression and its role in cancer development.
DESIGN: S100A4 abundance was analyzed by quantitative PCR (qPCR) in unaffected and tumor tissue from n = 73 PTC patients. The expression of PTCSC3 and S100A4 was studied in BCPAP and TPC-1 cell lines with forced expression of PTCSC3 by qPCR. Expression of S100A4 target genes (VEGF and MMP-9) was studied in the BCPAP cell line with forced expression of PTCSC3 by qPCR, reverse transcriptase PCR, and Western blot. The impact of PTCSC3 on BCPAP motility and invasiveness was analyzed by the Transwell and Matrigel assays, respectively.
SETTING: This was a laboratory-based study using cells from clinical samples and thyroid cancer cell lines. MAIN OUTCOME AND MEASURE: We aimed to find evidence for a link between the expression of PTCSC3 and thyroid carcinogenesis.
RESULTS: Expression data from PTC cell lines pinpointed S100A4 as the most significantly downregulated gene in the presence of PTCSC3. S100A4 was upregulated in tumor tissue (P = 9.33 × 10(-7)) while PTCSC3 was strongly downregulated (P = 2.2 × 10(-16)). S100A4 transcription was moderately correlated with PTCSC3 expression in unaffected thyroid tissue (r = 0.429, P = .0001), and strongly in unaffected tissue of patients with the risk allele of rs944289 (r = 0.685, P = 7.88 × 10(-5)). S100A4, VEGF, and MMP-9 were suppressed in the presence of PTCSC3 (P = .0051, P = .0090, and P =.0037, respectively). PTC cells expressing PTCSC3 showed reduction in motility and invasiveness (P = 4.52 × 10(-5) and P = 1.0 × 10(-4), respectively).
CONCLUSIONS: PTCSC3 downregulates S100A4, leading to a reduction in cell motility and invasiveness. We propose that PTCSC3 impacts PTC predisposition and carcinogenesis through the S100A4 pathway.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26274343      PMCID: PMC4596031          DOI: 10.1210/jc.2015-2247

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

1.  Discovery of common variants associated with low TSH levels and thyroid cancer risk.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Gisli Masson; Huiling He; Aslaug Jonasdottir; Asgeir Sigurdsson; Simon N Stacey; Hrefna Johannsdottir; Hafdis Th Helgadottir; Wei Li; Rebecca Nagy; Matthew D Ringel; Richard T Kloos; Marieke C H de Visser; Theo S Plantinga; Martin den Heijer; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; G Bragi Walters; Hjordis Bjarnason; Laufey Tryggvadottir; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Isleifur Olafsson; Kristleifur Kristjansson; Hoskuldur Kristvinsson; Olafur T Magnusson; Gudmar Thorleifsson; Jeffrey R Gulcher; Augustine Kong; Lambertus A L M Kiemeney; Thorvaldur Jonsson; Hannes Hjartarson; Jose I Mayordomo; Romana T Netea-Maier; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2012-01-22       Impact factor: 38.330

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 3.  The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.

Authors:  James J Manfredi
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

Review 4.  General mechanisms of metastasis.

Authors:  E C Woodhouse; R F Chuaqui; L A Liotta
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

5.  Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.

Authors:  Yutaka Maeda; Tomoshi Tsuchiya; Haiping Hao; David H Tompkins; Yan Xu; Michael L Mucenski; Lingling Du; Angela R Keiser; Takuya Fukazawa; Yoshio Naomoto; Takeshi Nagayasu; Jeffrey A Whitsett
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

6.  Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.

Authors:  Barry R Davies; Marie O'Donnell; Garrett C Durkan; Philip S Rudland; Roger Barraclough; David E Neal; J Kilian Mellon
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

7.  Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.

Authors:  Wen-Ying Lee; Wu-Chou Su; Pin-Wen Lin; How-Ran Guo; Tsai-Wang Chang; Helen H W Chen
Journal:  Oncology       Date:  2004       Impact factor: 2.935

8.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

9.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

10.  MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits.

Authors:  Hong Liu; Derek C Radisky; Dun Yang; Ren Xu; Evette S Radisky; Mina J Bissell; J Michael Bishop
Journal:  Nat Cell Biol       Date:  2012-05-13       Impact factor: 28.824

View more
  29 in total

1.  Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.

Authors:  Tao Li; Xiao-Dong Yang; Chun-Xiang Ye; Zhan-Long Shen; Yang Yang; Bo Wang; Peng Guo; Zhi-Dong Gao; Ying-Jiang Ye; Ke-Wei Jiang; Shan Wang
Journal:  Cell Cycle       Date:  2016-12-08       Impact factor: 4.534

2.  LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.

Authors:  Xiao-Ming Wang; Yang Liu; Yu-Xia Fan; Zheng Liu; Qing-Ling Yuan; Meng Jia; Zu-Shi Geng; Ling Gu; Xiu-Bo Lu
Journal:  Cancer Biol Ther       Date:  2018-05-03       Impact factor: 4.742

3.  LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p.

Authors:  Min Zhang; Yinghui Song; Lijuan Yu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway.

Authors:  Xiaoyu Li; Qinghuai Li; Xiao Jin; Hao Guo; Yong Li
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

5.  Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.

Authors:  Jarosław Jendrzejewski; Sandya Liyanarachchi; Andrew Eiterman; Andrew Thomas; Huiling He; Rebecca Nagy; Leigha Senter; Krzysztof Sworczak; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2018-12-03       Impact factor: 7.396

6.  Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.

Authors:  Jaroslaw Jendrzejewski; Sandya Liyanarachchi; Rebecca Nagy; Leigha Senter; Paul E Wakely; Andrew Thomas; Fadi Nabhan; Huiling He; Wei Li; Krzysztof Sworczak; Matthew D Ringel; Lawrence S Kirschner; Albert de la Chapelle
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

Review 7.  Non-Coding RNAs in Thyroid Cancer.

Authors:  Ranran Zhang; Heather Hardin; Jidong Chen; Zhenying Guo; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

Review 8.  Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis.

Authors:  Asumi Iesato; Carmelo Nucera
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

9.  Onco-lncRNA HOTAIR and its functional genetic variants in papillary thyroid carcinoma.

Authors:  Hui Zhu; Zheng Lv; Changming An; Meng Shi; Wenting Pan; Liqing Zhou; Wenjun Yang; Ming Yang
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

10.  Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.

Authors:  Jian-Jie Zhao; Shuai Hao; Ling-Li Wang; Chun-Yan Hu; Shu Zhang; Ling-Ji Guo; Gang Zhang; Bo Gao; Yan Jiang; Wu-Guo Tian; Dong-Lin Luo
Journal:  Oncotarget       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.